Pictorial presentation of subclinical atherosclerosis: a measure to reduce the risk for cardiovascular disease

↓ Direkt till sidans innehåll
↓ Direkt till sidans sekundära innehåll (sidomenyn)

Search: onr:"swepub:oai:DiVA.org:umu-186699" > Pictorial presentat...

1 of 1
Previous record
Next record
To hitlist

Details
MARC

Bengtsson, Anna,1973-Umeå universitet,Institutionen för epidemiologi och global hälsa (author)

Pictorial presentation of subclinical atherosclerosis : a measure to reduce the risk for cardiovascular disease

BookEnglish2021

Publisher, publication year, extent ...

Umeå :Umeå universitet,2021
85 s.
electronicrdacarrier

Numbers

LIBRIS-ID:oai:DiVA.org:umu-186699
ISBN:9789178555932
ISBN:9789178555925
https://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-186699URI

Supplementary language notes

Language:English
Summary in:English

Part of subdatabase

SwePubSwePub

Classification

Subject category:vet swepub-contenttype
Subject category:dok swepub-publicationtype

Varying forms of title

Visualisering av subklinisk ateroskleros :en metod för att minska risken för hjärt-kärlsjukdom

Series

Umeå University medical dissertations,0346-6612 ;2144

Notes

Zoom: https://umu.zoom.us/j/63352946259?pwd=MU5rVTdUZG1rMzVNTkIxaTl1czB1QT09 Password: 838770
The overall aim was improved cardiovascular disease (CVD) prevention through the VIPVIZA intervention. This includes the provision of pictorial information of subclinical atherosclerosis to participants and their general practitioners (GPs), follow-up phone call, and written information to the participant. VIPVIZA is a Prospective Randomized Open Blinded End-point (PROBE) trial nested within VIP, a CVD prevention program in primary health care in Västerbotten county, Sweden. Middle-aged individuals at low/intermediate CVD risk were enrolled to VIPVIZA and randomized 1:1 to an intervention (n=1749) or control group (n=1783 who received no pictorial or other information). Preventive measures were managed within primary health care.At baseline, clinical risk factors were measured and carotid ultrasound examination was performed. The prevalence of subclinical atherosclerotic disease was assessed as intima media thickness and presence of plaque. The association between clinical risk factors and measures of subclinical atherosclerosis was investigated. In addition to conventional risk factor-based risk evaluation, the impact of the VIPVIZA intervention on CVD risk, traditional risk factors and pharmacological treatment was evaluated after 1 and 3 years. Individual interviews were conducted with 15 GPs to explore how a pictorial representation of subclinical atherosclerosis affects physicians in their perception and communication of CVD risk. The interviews were analyzed by qualitative content analysis.The plaque prevalence was 44.7% in this population. Clinical risk factors explained more of the variation in a combined ultrasound measurement than single measurements. The results up to three years showed a VIPVIZA intervention effect, with lower and sustained CVD risk in the intervention as compared to the control group. The effect was partly mediated by differences in intake of lipid-lowering medication and partly by lifestyle behaviour. The GPs described their risk assessment and patients’ risk perception as more accurate with the VIPVIZA intervention. Informing patients about examination results prior to a consultation can facilitate shared decision-making and enhance adherence to preventive measures.The results show that the VIPVIZA intervention reduces CVD risk over three years. In the long run this has the potential to reduce the incidence of CVD events.

Subject headings and genre

MEDICIN OCH HÄLSOVETENSKAP Hälsovetenskap Folkhälsovetenskap, global hälsa, socialmedicin och epidemiologi hsv//swe
MEDICAL AND HEALTH SCIENCES Health Sciences Public Health, Global Health, Social Medicine and Epidemiology hsv//eng
MEDICIN OCH HÄLSOVETENSKAP Klinisk medicin Kardiologi hsv//swe
MEDICAL AND HEALTH SCIENCES Clinical Medicine Cardiac and Cardiovascular Systems hsv//eng
Cardiovascular disease
non-adherence
pictorial information
prevention
subclinical atherosclerosis

Added entries (persons, corporate bodies, meetings, titles ...)

Norberg, Margareta,DocentUmeå universitet,Institutionen för epidemiologi och global hälsa,Institutionen för folkhälsa och klinisk medicin(Swepub:umu)mano0062 (thesis advisor)
Fhärm, Eva,PhD, MDUmeå universitet,Allmänmedicin(Swepub:umu)evfh0001 (thesis advisor)
Wester, Per,Professor,1959-Umeå universitet,Avdelningen för medicin(Swepub:umu)pewe0002 (thesis advisor)
Hellénius, Mai-Lis,ProfessorInstitutionen för medicin, Karolinska Institutet, Solna (opponent)
Umeå universitetInstitutionen för epidemiologi och global hälsa (creator_code:org_t)

Internet link

Find in a library

Pictorial presentation of subclinical atherosclerosis a measure to reduce the ri... (Search the publication in LIBRIS)

To the university's database

1 of 1
Previous record
Next record
To hitlist

Find more in SwePub

By the author/editor: Bengtsson, Anna, ...; Norberg, Margare ...; Fhärm, Eva, PhD, ...; Wester, Per, Pro ...; Hellénius, Mai-L ...

About the subject

MEDICAL AND HEALTH SCIENCES: MEDICAL AND HEAL ...; and Health Sciences; and Public Health Gl ...

MEDICAL AND HEALTH SCIENCES: MEDICAL AND HEAL ...; and Clinical Medicin ...; and Cardiac and Card ...

Parts in the series: Umeå University ...

By the university: Umeå University

Search outside SwePub

Extend your search to:: Google; Google Book Search; Google Scholar

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

LIBRIS.kb.se